Lars Birkmann

Direttore Finanziario/CFO presso ACHIKO AG

46 anni

Technology Services

Health Technology

Profilo

Lars Birkmann is currently the Chief Financial Officer at Achiko AG since 2022.
Prior to this, he worked as the Chief Financial Officer at Ender Diagnostics AG.

Posizioni attive di Lars Birkmann

Società	Posizione	Inizio
ACHIKO AG	Direttore Finanziario/CFO	05/10/2022

Tutte le posizioni attive di Lars Birkmann

Precedenti posizioni note di Lars Birkmann

Società	Posizione	Fine
Ender Diagnostics AG Ender Diagnostics AG Medical SpecialtiesHealth Technology Ender Diagnostics AG is a Swiss private company that specializes in developing molecular diagnostic test kits for the rapid and reliable detection of SARS-CoV-2, the virus that causes COVID-19. The company has its headquarters in Bern, CH, and a subsidiary with offices in the US. The team at Ender Diagnostics has extensive experience in developing molecular biological rapid tests for infectious diseases. The company is supported by several private investors with know-how and financing. Ender Diagnostics was founded in 2019, and the CEO is Paul Senn.	Direttore Finanziario/CFO	-

Vedi nel dettaglio l'esperienza di Lars Birkmann

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lars Birkmann

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ACHIKO AG	Technology Services

Aziende private	1
Ender Diagnostics AG Ender Diagnostics AG Medical SpecialtiesHealth Technology Ender Diagnostics AG is a Swiss private company that specializes in developing molecular diagnostic test kits for the rapid and reliable detection of SARS-CoV-2, the virus that causes COVID-19. The company has its headquarters in Bern, CH, and a subsidiary with offices in the US. The team at Ender Diagnostics has extensive experience in developing molecular biological rapid tests for infectious diseases. The company is supported by several private investors with know-how and financing. Ender Diagnostics was founded in 2019, and the CEO is Paul Senn.	Health Technology